Nationwide Industrial Hemp Council Lauds Pres. Biden’s Nomination To Lead FDA: Dr. Robert Califf

President Joe Biden reappoints former Food and Drug Administration Commissioner Robert M. Califf as head of the agency. Califf, 70, a cardiologist and clinical trial specialist, most recently served as FDA commissioner 11 months President Barack Obama’s second term. Before that, he was a researcher for over 35 years Duke University, where he helped design studies for many of the world’s largest drug manufacturers, AP reported.

“With the FDA considering many follow-up decisions related to vaccine approvals and more, it is vital that we have a steady, independent hand to guide the FDA,” Biden said in a statement.

Califf was among the first FDA officials to publicly acknowledge this Missteps in the authority’s oversight of pain relievers like OxyContin, widely blamed for starting the ongoing opioid epidemic now fueled by heroin and fentanyl.

The National Council for Industrial Hemp (NIHC) praised the nomination as a necessary step in the direction of new leadership at the agency that has given oversight over hemp products consumed.

“The Senate-approved leadership at the FDA will improve consumer safety for cannabidiol and prepare the pump to build a hemp economy that works for everyone,” said NIHC spokesman Larry Farnsworth said Hemp Industry Daily.

If approved by the Senate, Califf would oversee decisions that will affect the cannabis industry.

Califf hasn’t said anything publicly about cannabinoids like CBD.

Photo courtesy of Wikimedia Commons

© 2021 Benzinga does not offer investment advice. All rights reserved.